Covered recipient · General Payments record
MARGARET BASILIADIS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2023
$912.08
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $298.82 | 12 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $205.55 | 6 |
| Novo Nordisk AS | $29.68 | 2 |
| Janssen Pharmaceuticals, Inc | $19.44 | 1 |
| Lilly USA, LLC | $16.08 | 1 |
| Metacel Pharmaceuticals LLC | $15.03 | 1 |
| PFIZER INC. | $13.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $20.22 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996215037 | CMS |
| AbbVie Inc. | $13.14 | 01/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996215039 | CMS |
| AbbVie Inc. | $8.16 | 01/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996215041 | CMS |
| AbbVie Inc. | $8.00 | 02/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996215043 | CMS |
| AbbVie Inc. | $84.85 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996215045 | CMS |
| AbbVie Inc. | $71.18 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996215047 | CMS |
| Janssen Pharmaceuticals, Inc | $19.44 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988131243 | CMS |
| Lilly USA, LLC | $16.08 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031885865 | CMS |
| Metacel Pharmaceuticals LLC | $15.03 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 979417683 | CMS |
| Novo Nordisk Inc | $14.55 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002784075 | CMS |
| Novo Nordisk Inc | $15.13 | 03/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002784089 | CMS |
| PFIZER INC. | $13.04 | 01/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049122689 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.